Login / Signup

Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage.

Małgorzata M MillerJessica LoweMuhib KhanMuhammad U AzeemSusanne MuehlschlegelAdalia H Jun-O'ConnellRichard P GoddeauMajaz MoonisDanielle GrittersBrian SilverNils Henninger
Published in: Neurocritical care (2020)
DOAC use did not relate to worse HE, HV, and functional outcome after ICH, adding to the notion that DOAC is a safe alternative to VKA even in the absence of access to targeted reversal strategies (which are still not universally available).
Keyphrases
  • direct oral anticoagulants
  • venous thromboembolism
  • atrial fibrillation
  • brain injury
  • cancer therapy